Bioavailability of labetalol increases with age

Area of Science:

• Pharmacology
• Geriatric Medicine
• Cardiovascular Research

Background:

• Labetalol is an antihypertensive medication.
• Age can affect drug pharmacokinetics.

Purpose of the Study:

• To investigate the effect of age on labetalol pharmacokinetics.
• To determine if labetalol dosing needs adjustment in elderly patients.

Main Methods:

• Oral and intravenous administration of labetalol.
• Study conducted on ten hypertensive patients aged 28-75 years.

Main Results:

• Significant increase in labetalol bioavailability and half-life with age.
• Lower clearance observed in elderly subjects.
• Increased first-pass metabolism in the elderly leads to higher oral bioavailability.

Conclusions:

• Age significantly impacts labetalol pharmacokinetics, particularly bioavailability and half-life.
• Elderly patients exhibit increased oral bioavailability of labetalol due to altered first-pass metabolism.
• Dosing adjustments for labetalol may be necessary in the elderly population.